Brought to you by:
-
Trainee wellness: ‘No one really prepared me for the failures’
Communication and an awareness of how often vascular surgery fails emerged as key talking points during a Vascular Surgery Interest Group (VSIG) Lunch Symposium panel discussion aimed at providing trainees and medical students with career guidance during the Western Vascular Society (WVS) 2021 annual meeting in Jackson Hole, Wyoming (Oct. 16-19). Faculty and residents provided…
-
Re-visit VAM: Watch sessions you missed
Registrants for the 2021 Vascular Annual Meeting (VAM) can now catch sessions they may have missed in San Diego—or otherwise review a critical presentation at their own leisure. Select recordings of VAM sessions are now available on the SVS OnDemand page at SVSOnDemand.vascular.org. These sessions are part of the VAM21 Collection. The Vascular Quality Initiative…
-
SVS Foundation seeks auction items for VAM 2022 Gala
The SVS Foundation is planning what promises to be 2022’s party of the year—and needs the help of Society for Vascular Surgery (SVS) members. The Foundation Gala is set for Friday, June 17, during the 2022 Vascular Annual Meeting (VAM) in Boston. This iteration of the Gala will be an extra-special part of the meeting,…
-
WVS 2021: Western Vascular Society names new president-elect
University of Southern California (USC) vascular chief Vincent Rowe, MD, took over as the new president of the Western Vascular Society (WVS)—with University of Arizona chief of vascular surgery Wei Zhou, MD, named the new president-elect—during the organization’s 2021 annual meeting in Jackson Hole, Wyoming, held Oct. 16–19. Rowe succeeds Michael S. Conte, MD, the…
-
WVS 2021: Community surgeons report improved rAAA survival after adoption of EVAR-first approach
Overall survival improved from 71% to 80% after a group of community practice surgeons started using an endovascular-first approach to ruptured abdominal aortic aneurysm (rAAA) repair. Scott S. Berman, MD, a vascular surgeon at Pima Heart & Vascular in Tucson, Arizona, revealed the finding during a rapid-fire presentation offering a look at his practice’s experience…
-
ACS, ACST-2, Carotid disease, CEA, DCBs, Diversity, Eastern Vascular Society, EVS, Imaging, Midwestern Vascular Surgical Society, MVSS, PAD, PCBs, VAM
The top 10 most popular Vascular Specialist stories in September
Five-year data from the ACST-2 trial comparing carotid endarterectomy and carotid artery stenting, a report from the Crawford Forum at the 2021 Vascular Annual Meeting (VAM), and an Eastern Vascular Society (EVS) annual meeting piece reporting on vascular surgery as a healthcare system’s “enabling service” were among the most-read stories on the Vascular Specialist website in…
-
Three-year VIVO results back ‘continued safety and effectiveness’ of Zilver Vena venous stent
Three-year results of the VIVO clinical study support the continued safety and effectiveness of the Zilver Vena venous stent (Cook Medical) in the treatment of symptomatic iliofemoral venous outflow obstruction, attendees at the Vascular Interventional Advances (VIVA) 2021 (Oct. 5–7) in Las Vegas. Paul Gagne, MD, a vascular surgeon and an associate clinical professor of surgery at New…
-
ClotTriever, deep vein thrombosis, DVT, Eastern Vascular Society, EVS, Inari Medical, Venous disease
Registry data show greater clot chronicity on post-procedure inspection than initially predicted
Nearly half of patients deemed pre-procedurally to be suffering an acute case of deep vein thrombosis (DVT) turned out to have a “much more” chronic classification of the condition following intraoperative imaging and thrombus inspection post-procedure, an interim analysis from the CLOUT registry demonstrated. The cohort study was presented at the Eastern Vascular Society (EVS)…
-
PROMISE I 24-month results ‘validate the benefits of the LimFlow system’
LimFlow has announced 24-month results from the PROMISE I study of the LimFlow percutaneous deep vein arterialization system, confirming “excellent and sustained outcomes” for both amputation-free survival and wound healing, a press release reports. The late-breaking data were presented at Vascular Interventional Advances (VIVA) 2021 (Oct. 5–7) in Las Vegas. “The presentation of the PROMISE…
-
Carotid disease, carotid endarterectomy, Midwestern Vascular Surgical Society, MVSS, ROADSTER, stroke, TCAR
‘TCAR yields high technical success with an extraordinarily low stroke and death rate at one year’
Outcomes in a cohort of patients who consented to one year of follow-up after transcarotid revascularization (TCAR) treatment for carotid stenosis in the ROADSTER 2 trial showed a 97.4% rate of technical success, no incidences of ipsilateral stroke and a 2.6% mortality rate, the 2021 annual meeting of the Midwestern Vascular Surgical Society (Sept. 9–11)…